| Dr Ivan J Sosa Gonzalez, MD | |
|
100 Ave Luis Munoz Marin, Caguas, PR 00725-6184 | |
| (787) 653-3434 | |
| (787) 961-1913 |
| Full Name | Dr Ivan J Sosa Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 27 Years |
| Location | 100 Ave Luis Munoz Marin, Caguas, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982633368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 12968 (Puerto Rico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mennonite General Hospital Inc | 6709843964 | 71 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
| Entity Name | Recinto De Ciencias Medicas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720163058 PECOS PAC ID: 3678469962 Enrollment ID: O20040424000410 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
| Entity Name | Hospital Menonita De Cayey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750317764 PECOS PAC ID: 2466449657 Enrollment ID: O20040429000135 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
| Entity Name | Mennonite General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851320394 PECOS PAC ID: 6709843964 Enrollment ID: O20041220000467 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ivan J Sosa Gonzalez, MD Po Box 4980, Caguas, PR 00726-4980 Ph: (787) 615-0686 | Dr Ivan J Sosa Gonzalez, MD 100 Ave Luis Munoz Marin, Caguas, PR 00725-6184 Ph: (787) 653-3434 |
News Archive
The link between Hormone Replacement Therapy and reduced risk of distal large bowel cancer in women; a promising combination antibiotic therapy for ulcerative colitis patients; and the high-rate of alcoholic liver disease mortality, are among the scientific findings featured in the August issue of The American Journal of Gastroenterology.
BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.
A new study finds that concussion causes short-term impairment of the cardiovascular system but that these cardiovascular symptoms typically resolve within three days of the injury.
A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role in the development of novel tailor-made cancer drugs.
An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
› Verified 2 days ago
Luis Jose Almodovar Fabregas, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Ave L Munoz Marin Ste 706, Caguas, PR 00725 Phone: 787-653-2217 | |
Dr. Emil Antonio Pastrana Ramirez, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Ave Luis Munoz Marin Hima Plaza I, Suite 706, Caguas, PR 00725 Phone: 787-648-9001 Fax: 787-903-5130 | |
Dr. Yadira Dacosta, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Hospital Hima Caguas, Ave Luis Munoz Marin Urb Mariolga, Caguas, PR 00726 Phone: 787-653-3434 |